drugset / Trial / NCT05508334
A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours
NaSequentialOpen-labelTreatment
Summary
The purpose of this study is to allow RC88 treatment of patients with advanced solid tumours to assess the safety and tolerability of clinical pharmacology studies
Timeline
- Start
- 2023-01-30
- Primary completion
- 2025-11-26
- Completion
- 2025-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RC88 | Unknown | — | Intravenous |